Business
Mesoblast share price crashes 29% lower on FDA doubts – Motley Fool Australia
The Mesoblast limited (ASX:MSB) share price is crashing lower on Tuesday after doubts were raised ahead of its key FDA meeting…
The Mesoblast limited(ASX: MSB) share price has been the worst performer on the S&P/ASX 200 Index (ASX: XJO) by some distance on Tuesday.
In afternoon trade the biotechnology company’s shares are down 26% to $3.62.
At one stage, the Mesoblast share price was down as much as 29% to $3.46.
Why is the Mesoblast share price crashing lower?
Investors have been hitting the sell button in a panic on Tuesday after the U.S. Food and Drug Administration (FDA) released a briefing document ahead of …
-
Noosa News14 hours agoQueen Street Mall to get a 3D digital billboard; Dutton dumps controversial plans to end flexible work; Measles alert for tourist hotspots
-
Business18 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business17 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News15 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites